Moreover, a high expression of TRPM7, USP8, GABPB1, or SPPL2A was shown to be associated with shorter survival times in cutaneous melanomas (Log-rank TRPM7, p-value = 0.005; Log-rank USP8, p-value = 0.017; Log-rank GABPB1, p-value = 0.019; and Log-rank GABPB1, p-value = 0.022) (https://www.proteinatlas.org, accessed on 1 July 2021). This evidence concerns the gene SPPL2A and cutaneous melanoma.